218 related articles for article (PubMed ID: 21628879)
1. Roles of coagulation pathway and factor Xa in the progression of diabetic nephropathy in db/db mice.
Sumi A; Yamanaka-Hanada N; Bai F; Makino T; Mizukami H; Ono T
Biol Pharm Bull; 2011; 34(6):824-30. PubMed ID: 21628879
[TBL] [Abstract][Full Text] [Related]
2. [Roles of coagulation pathway and factor Xa in chronic kidney disease (CKD)].
Ono T
Yakugaku Zasshi; 2012; 132(4):449-53. PubMed ID: 22465921
[TBL] [Abstract][Full Text] [Related]
3. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
[TBL] [Abstract][Full Text] [Related]
4. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
[TBL] [Abstract][Full Text] [Related]
5. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
6. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
8. Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis.
Nomura K; Liu N; Nagai K; Hasegawa T; Kobayashi I; Nogaki F; Tanaka M; Arai H; Fukatsu A; Kita T; Ono T
Lab Invest; 2007 Feb; 87(2):150-60. PubMed ID: 17179958
[TBL] [Abstract][Full Text] [Related]
9. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
10. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
11. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
Wang SN; Hirschberg R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
[TBL] [Abstract][Full Text] [Related]
12. Early Enhanced Leucine-Rich
Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
14. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist.
Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446
[TBL] [Abstract][Full Text] [Related]
15. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
[TBL] [Abstract][Full Text] [Related]
16. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D; Maeshima Y; Nasu T; Yamasaki H; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F873-86. PubMed ID: 21228103
[TBL] [Abstract][Full Text] [Related]
18. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats.
Liu N; Makino T; Nogaki F; Kusano H; Suyama K; Muso E; Honda G; Kita T; Ono T
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F612-20. PubMed ID: 15172885
[TBL] [Abstract][Full Text] [Related]
19. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.
Reddy MA; Sumanth P; Lanting L; Yuan H; Wang M; Mar D; Alpers CE; Bomsztyk K; Natarajan R
Kidney Int; 2014 Feb; 85(2):362-73. PubMed ID: 24088954
[TBL] [Abstract][Full Text] [Related]
20. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
